Washington, April 20, 2022 – Batavia Biosciences was honored this week during the Vaccine Industry Excellence (ViE) Awards show at the World Vaccine Congress with the award for Best Production/Process Development. The ViE Awards provide a time and place to celebrate the industry’s most outstanding achievements showcasing excellence in the global vaccine industry. Being recognized for the award is affirmation and a testament to the employees incredible work at Batavia. Helping to reduce human suffering and provide affordable and equitable access of vaccines to everyone has been and will continue to be our goal.
Judges at the ViE Awards evaluated Batavia and other shortlisted competitors looking for evidence and examples around 5 major areas:
- Demonstration of ongoing commitment to provide production technology globally and reducing lead times for its customers
- Demonstration of end-to-end suite solutions to customers
- Demonstration of outstanding thought leadership and spearheading innovation
- Raising the bar on process standards
- Demonstration of quality of relationships with clients
Batavia was able to provide sound evidence for each category and take home the prestigious award. Batavia is a Center of Excellence CDMO and next to providing high quality services, we provide thought partnership, share best practices, perform research, and provide support.
Menzo Havenga, CEO Batavia Biosciences, says: “I am proud of what we have achieved with Batavia in the past 12 years. This award is a great recognition for our efforts to make vaccine manufacturing more affordable to support accessibility for all in need.”
We would also like to congratulate other shortlisted candidates for the Best Productions/Process Development award; Moderna, LumaCyte, Millipore Sigma, Sartorius Stedim Biotech, BD Medical, Pharmaceutical Systems, and Eppendorf.